UPDATE: Instil Bio Q3 Adj EPS $(0.16) Misses $(0.10) Estimate
Portfolio Pulse from Benzinga Newsdesk
Instil Bio (NASDAQ:TIL) reported a Q3 adjusted EPS loss of $(0.16), missing the analyst consensus estimate of $(0.10) by 60%. However, this represents a 62.79% improvement from the $(0.43) per share loss in the same quarter last year.
November 13, 2023 | 10:50 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Instil Bio reported a larger-than-expected Q3 loss per share of $(0.16), missing estimates by 60%, but improved from last year's $(0.43) loss.
Missing the EPS estimate by 60% is likely to negatively impact investor sentiment in the short term. However, the improvement from the previous year's loss may provide some positive context. The direct mention and the nature of the news make it highly relevant and important for investors, but the confidence in the score is not absolute due to potential mitigating factors such as overall market conditions or company-specific news not mentioned in the article.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100